This company listing is no longer active
NBLY Stock Overview
Neighbourly Pharmacy Inc. owns and operates a chain of retail pharmacies in Canada. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
Neighbourly Pharmacy Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$18.54 |
| 52 Week High | CA$23.00 |
| 52 Week Low | CA$12.05 |
| Beta | 0.29 |
| 1 Month Change | 0.93% |
| 3 Month Change | 10.82% |
| 1 Year Change | -13.36% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -17.56% |
Recent News & Updates
Recent updates
Neighbourly Pharmacy (TSE:NBLY) Will Pay A Dividend Of CA$0.045
Aug 15
Estimating The Fair Value Of Neighbourly Pharmacy Inc. (TSE:NBLY)
Mar 22Results: Neighbourly Pharmacy Inc. Delivered A Surprise Loss And Now Analysts Have New Forecasts
Feb 17Calculating The Fair Value Of Neighbourly Pharmacy Inc. (TSE:NBLY)
Dec 09Neighbourly Pharmacy's (TSE:NBLY) Robust Earnings Are Supported By Other Strong Factors
Aug 10News Flash: Analysts Just Made A Substantial Upgrade To Their Neighbourly Pharmacy Inc. (TSE:NBLY) Forecasts
Mar 21Is There An Opportunity With Neighbourly Pharmacy Inc.'s (TSE:NBLY) 48% Undervaluation?
Feb 27Shareholder Returns
| NBLY | CA Consumer Retailing | CA Market | |
|---|---|---|---|
| 7D | 0.05% | -2.0% | 1.8% |
| 1Y | -13.4% | 20.2% | 11.2% |
Return vs Industry: NBLY underperformed the Canadian Consumer Retailing industry which returned 22.7% over the past year.
Return vs Market: NBLY underperformed the Canadian Market which returned 8.9% over the past year.
Price Volatility
| NBLY volatility | |
|---|---|
| NBLY Average Weekly Movement | 5.0% |
| Consumer Retailing Industry Average Movement | 3.9% |
| Market Average Movement | 9.6% |
| 10% most volatile stocks in CA Market | 17.7% |
| 10% least volatile stocks in CA Market | 4.1% |
Stable Share Price: NBLY has not had significant price volatility in the past 3 months.
Volatility Over Time: NBLY's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2015 | 3,648 | Skip Bourdo | neighbourlypharmacy.ca |
Neighbourly Pharmacy Inc. owns and operates a chain of retail pharmacies in Canada. The company sells prescription medication, confections and food, over the counter drugs, and health and beauty aids. It operates pharmacies under the various banners, such as IDA/Guardian, Pharmachoice, Pharmasave, Remedy’s RX, and Drug Trading.
Neighbourly Pharmacy Inc. Fundamentals Summary
| NBLY fundamental statistics | |
|---|---|
| Market cap | CA$840.40m |
| Earnings (TTM) | -CA$32.70m |
| Revenue (TTM) | CA$874.61m |
1.0x
P/S Ratio-25.6x
P/E RatioIs NBLY overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NBLY income statement (TTM) | |
|---|---|
| Revenue | CA$874.61m |
| Cost of Revenue | CA$527.56m |
| Gross Profit | CA$347.05m |
| Other Expenses | CA$379.76m |
| Earnings | -CA$32.70m |
Last Reported Earnings
Dec 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.72 |
| Gross Margin | 39.68% |
| Net Profit Margin | -3.74% |
| Debt/Equity Ratio | 44.5% |
How did NBLY perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/03/20 02:54 |
| End of Day Share Price | 2024/03/20 00:00 |
| Earnings | 2023/12/30 |
| Annual Earnings | 2023/03/25 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Neighbourly Pharmacy Inc. is covered by 10 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Clarence Powell | BMO Capital Markets Equity Research |
| Kyle McPhee | Cormark Securities Inc. |
| Christopher Li | Desjardins Securities Inc. |